Tuberculosis and treatment with infliximab.
Riminton
Sean
S
Pearce
Nicholas
N
Antony
Basten
B
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D004198:Disease Susceptibility / Q000276:immunology*; D006801:Humans; D000069285:Infliximab; D051379:Mice; D008810:Mice, Inbred C57BL; D009026:Mortality; D014376:Tuberculosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000172:deficiency
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab